how to actually pick a treatment center when youre looking at surgery plus chemo

Your questions are exactly the right ones. The volume question especially, peritoneal cases specifically, not just "we do a lot of cancer surgery." There's a real difference and the research backs this up. Centers doing fewer than roughly 15 to 20 HIPEC procedures a year tend to have meaningfully worse outcomes, and that's not me being harsh, that's what the data shows.

The thing that actually mattered most for the families I've worked with was whether the surgical oncologist and the medical oncologist were in the same room when the plan was made. Not consulting by email. Actual tumor board. If a center can't tell you when their multidisciplinary tumor board meets and whether your case would be presented there, that tells you something.

The marketing speak you got when you asked about complication rates... I've heard that so many times and it never stops being frustrating. A good center will give you real numbers even when those numbers are uncomfortable. In my experience working with peritoneal meso patients since around 2013, the ones who pushed hardest for specifics generally ended up at better centers, not because asking magically changes anything but because the centers that welcome those questions are usually the ones worth choosing.

Your journal from August is actually something I'd bring to every single consultation, not just as a symptom tracker but as evidence of how thorough you are. Surgeons notice that.

If you haven't already connected with the Mesothelioma Applied Research Foundation, they maintain a list of specialized centers and can sometimes help you think through what to ask. And if the emotional weight of all this decision-making starts feeling like too much to carry alone, talking to a counselor who works specifically with cancer patients can help you think more clearly, not just feel better.

Your questions are exactly the right ones, and the fact that a center gave you marketing speak when you asked about complication rates tells you something real about them.

In my work with peritoneal meso patients, the volume question matters more than almost anything else. There's actually research suggesting outcomes improve significantly at centers doing 15 or more cytoreduction/HIPEC procedures per year, not 15 cancer surgeries total. Those are very different numbers and most centers won't volunteer that distinction.

The integrated team piece is the one I've seen trip people up the most. I worked with a patient in early 2022 who chose a center because the surgeon was exceptional, and she didn't find out until after her cytoreduction that the oncologist managing her post-op chemo had never treated peritoneal meso specifically. The coordination just wasn't there. The surgeon and the oncologist need to be in the same room making decisions together, ideally from the very first consult.

When you're talking to these centers, asking for their specific HIPEC protocol in writing is something that's gotten real results for people I've supported. A center confident in their approach will share it. One that hedges is telling you something.

And honestly... your symptom journal and the fact that you've been tracking since August, that's going to be useful in those consults in ways people underestimate. Bring all of it.

If the weight of this decision is feeling like a lot to carry, talking with an oncology social worker at whichever center you're considering is worth doing. That's what we're there for, and it's separate from the medical piece.

The integrated team piece is something I want to expand on because it matters more than most people realize when they're in your position.

The Sugarbaker technique (the surgical approach most centers use for peritoneal meso) was designed with the assumption that the surgeon and medical oncologist are essentially co-managing the case from day one, not handing off a patient like a relay race. When I've seen outcomes diverge between centers doing similar case volumes, that handoff gap is often where things go sideways. You asked whether the same surgical team consults on the chemo plan, and honestly that question alone will tell you a lot. If they have to pause and say "well we'd refer you back to your local oncologist for systemic therapy," that's your answer.

One thing nobody's mentioned yet: ask specifically about their tumor board. Not just whether they have one, but whether peritoneal cases go to a dedicated GI or peritoneal malignancy board or just the general oncology tumor board. There's a real difference in the depth of conversation that happens. A center doing 20 peritoneal cases a year that reviews each one with a dedicated multidisciplinary group is going to think differently than one where your case gets 8 minutes between a lung case and a lymphoma case.

Talk to your own oncologist about all of this, but the questions you're already asking are exactly the right ones.

Your list of questions is honestly one of the best I've seen someone put together this early. Twelve years working with peritoneal patients and I still sometimes have to walk people through getting to exactly this point.

The case volume question matters more than almost anything else. A 2019 study out of the Peritoneal Surface Oncology Group found outcomes improved significantly at centers doing more than 40 HIPEC cases annually, and a lot of facilities advertising "HIPEC" are doing maybe 8 to 12. When I was helping a patient in a similar situation in 2022, she specifically asked for a number and the coordinator couldn't give one without checking. That told her something.

The integrated team piece is real. If the surgeon and the medical oncologist aren't in the same tumor board meeting talking about your specific case together, the coordination can fall apart in ways that don't show up until complications happen. You want to ask who presents your case and who's in the room.

And honestly? The marketing speak you described from that first hospital would have made me nervous too. Centers that are confident in their outcomes tend to be more specific, not less.

Given that you have Stage II and you're in Cleveland, the MSK Peritoneal Disease program and the program at Wake Forest have both been places my patients have gotten second opinions that changed their treatment plans. Talk to your own doctor about what makes sense geographically.

If you're finding the decision-making process itself overwhelming, journaling what your gut is saying after each consultation can really clarify things. And if anxiety is making it hard to process information, a counselor who works specifically with cancer patients can help with that part. It's worth asking the center you choose if they have one on staff.